vaccine development

A public-private victory that should go down in U.S. history. Photographer: Ulrich Baumgarten/Getty Images
Coronavirus chronicle

White House considering intellectual property waiver for Covid-19 vaccines

The United States and several other countries have thus far blocked negotiations at the World Trade Organization (WTO) about a proposal led by India and South Africa that would waive the IP rights...

The White House is pictured shortly after sunrise in Washington/Reuters
Coronavirus chronicle

WH uncertain over lifting curbs on vaccine raw materials export to India

A healthcare worker prepares to administer a dose of the Oxford University-AstraZeneca vaccine, marketed by the Serum Institute of India (SII) as COVISHIELD, against the coronavirus disease (COVID-19), in Santiago, Dominican Republic February 17, 2021. REUTERS/Ricardo Rojas/File Photo
Coronavirus chronicle

India has supplied about 60 million Covid-19 vaccine doses to other countries

Photo: Collected
Coronavirus chronicle

EU regulator urges caution on Sputnik Covid-19 vaccine

A health worker prepares an injection with a dose of Astra Zeneca coronavirus vaccine, at a vaccination centre in Westfield Stratford City shopping centre, amid the outbreak of coronavirus disease (COVID-19), in London, Britain, February 18, 2021. REUTERS/Henry Nicholls
Coronavirus chronicle

UK finds vaccines 80% effective at preventing risks in over-80s

FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha
Coronavirus chronicle

Serum Institute says prioritising domestic vaccine needs, asks for patience

Photo provided by Russian Direct Investment Fund (RDIF) shows a researcher working in a laboratory of the Gamaleya Scientific Research Institute of Epidemiology and Microbiology in Moscow, Russia.Photo:Xinhua via UNB
Coronavirus chronicle

EU to launch programme for ‘second generation’ Covid-19 vaccines

FILE PHOTO: An employee holds a vial containing CoronaVac, Sinovac Biotech's vaccine against the coronavirus disease (COVID-19), at Butantan biomedical production center in Sao Paulo, Brazil January 12, 2021. REUTERS/Amanda Perobelli
Coronavirus chronicle

Covid-19 shots might be tweaked if variants get worse

Jim O’Neill/ Former treasury minister, United Kingdom
Thoughts

Reflections on a plague year